Xue L. Kwang
11 Hospital Crescent
Singapore, 169610, Singapore
Singapore, 169610, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors.
Journal: Developmental cell
Published: November 01, 2023
Bioengineered Hydrogels Recapitulate Fibroblast Heterogeneity in Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 27, 2023
Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib.
Journal: Lung Cancer (Auckland, N.Z.)
Published: September 08, 2020
Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.
Journal: Oral oncology
Published: December 19, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 25, 2019
Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy.
Journal: Nature communications
Published: August 31, 2018
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.
Journal: Nature medicine
Published: June 17, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026